Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice

Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Agnes Carolin, Kexin Yan, Cameron R. Bishop, Bing Tang, Wilson Nguyen, Daniel J. Rawle, Andreas Suhrbier
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556745/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice.
by: Agnes Carolin, et al.
Published: (2024-01-01)

Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice
by: Kotou Sangare, et al.
Published: (2025-01-01)

Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice.
by: Jacklyn R Hurst, et al.
Published: (2024-01-01)

Functional heterogeneity of mesenchymal stem cells and their therapeutic potential in the K18-hACE2 mouse model of SARS-CoV-2 infection
by: Kátia Nunes da Silva, et al.
Published: (2025-01-01)

Elimination of olfactory sensory neurons by zinc sulfate inoculation prevents SARS-CoV-2 infection of the brain in K18-hACE2 transgenic mice
by: Ji-Hun Lee, et al.
Published: (2024-11-01)

Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan
by: Li-Teh Liu, et al.
Published: (2023-10-01)

A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
by: Zhe Chen, et al.
Published: (2025-01-01)

The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development
by: Zhen Zhang, et al.
Published: (2024-12-01)

Author Correction: Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan
by: Li-Teh Liu, et al.
Published: (2024-11-01)

The effect of SARS-CoV-2 Omicron BA. 5.2 infection on perioperative physiological indicators in orthopedic patients
by: Hao Wu, et al.
Published: (2025-01-01)

SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein
by: Simone Parn, et al.
Published: (2022-12-01)

Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients
by: Inga Tometten, et al.
Published: (2025-01-01)

Characterization of a SARS-CoV-2 Omicron BA.5 direct-contact transmission model in hamsters
by: Kim Handrejk, et al.
Published: (2024-11-01)

Calceolarioside B inhibits SARS-CoV-2 Omicron BA.2 variant cell entry and modulates immune response
by: Xiao-bin Lin, et al.
Published: (2024-12-01)

Coronil effectively inhibits the interaction of clinically relevant Omicron mutants of SARS-CoV-2 spike proteins with human ACE2 receptor
by: Acharya Balkrishna, et al.
Published: (2025-02-01)

Protection conferred by booster vaccine doses in hospitalized patients with COVID-19 during the SARS-CoV-2 Omicron BA.2 and BA.5 epidemics from 2022 to 2023 in Greece
by: Helena C. Maltezou, et al.
Published: (2024-12-01)

Beta-variant recombinant SARS CoV-2 vaccine induces durable cross-reactive antibodies against Omicron BA variants
by: Odile Launay, et al.
Published: (2025-01-01)

Rapid detection of the SARS-CoV-2 omicron variants based on high-resolution melting curve analysis
by: Yue Cheng, et al.
Published: (2024-11-01)

SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1
by: Qian Wang, et al.
Published: (2024-12-01)

A comprehensive immune repertoire signature distinguishes pulmonary infiltration in SARS-CoV-2 Omicron variant infection
by: Xuechuan Li, et al.
Published: (2024-12-01)

Development of ACE2 autoantibodies after SARS-CoV-2 infection.
by: John M Arthur, et al.
Published: (2021-01-01)

Structure and dynamics of the interaction of Delta and Omicron BA.1 SARS-CoV-2 variants with REGN10987 Fab reveal mechanism of antibody action
by: Ekaterina N. Lyukmanova, et al.
Published: (2024-12-01)

Rapid spread of the SARS-CoV-2 Omicron XDR lineage derived from recombination between XBB and BA.2.86 subvariants circulating in Brazil in late 2023
by: Ighor Arantes, et al.
Published: (2025-01-01)

Correction: Development of ACE2 autoantibodies after SARS-CoV-2 infection.
by: John M Arthur, et al.
Published: (2024-01-01)

Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant
by: Byung Uk Lee
Published: (2021-12-01)

Daphnetin may protect from SARS-CoV-2 infection by reducing ACE2
by: Qian-wen Yang, et al.
Published: (2024-12-01)

The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity
by: Alba Escalera, et al.
Published: (2024-12-01)

Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variantsResearch in context
by: Lok Bahadur Shrestha, et al.
Published: (2024-12-01)

Immune evasion after SARS-CoV-2 Omicron BA.5 and XBB.1.9 endemic observed from Guangdong Province, China from 2022 to 2023
by: Huan Zhang, et al.
Published: (2024-11-01)

From Emergence to Evolution: Dynamics of the SARS-CoV-2 Omicron Variant in Florida
by: Sobur Ali, et al.
Published: (2024-12-01)

Comparative Evolutionary Epidemiology of SARS-CoV-2 Delta and Omicron Variants in Kuwait
by: Moh A. Alkhamis, et al.
Published: (2024-11-01)

Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
by: Marzia Cavalli, et al.
Published: (2025-01-01)

Antiviral activity of an ACE2-Fc fusion protein against SARS-CoV-2 and its variants.
by: Ernesto Bermúdez-Abreut, et al.
Published: (2025-01-01)

In vivo production of engineered ACE2 decoy protects lungs from SARS-CoV-2 infection
by: Yuta Suzuki, et al.
Published: (2025-03-01)

Can ACE2 expression explain SARS‐CoV‐2 infection of the respiratory epithelia in COVID‐19?
by: Martijn C Nawijn, et al.
Published: (2020-07-01)

La escuela hace cine, el cine hace escuela.
by: Ileana Versace
Published: (2015-12-01)

Altered plasma levels of the SARS-CoV-2-related proteins ACE2 and TMPRSS2 in patients with Crohn’s disease
by: Jorge Sáez-Leyva, et al.
Published: (2024-12-01)

Antigenicity assessment of SARS-CoV-2 saltation variant BA.2.87.1
by: Sijie Yang, et al.
Published: (2024-12-01)

First detection of Omicron variant BA.4.1 lineage in dogs, Chile
by: B. Agüero, et al.
Published: (2024-12-01)

Spectroscopic signatures and origin of hidden order in Ba2MgReO6
by: Jian-Rui Soh, et al.
Published: (2024-11-01)